2019
DOI: 10.22543/7674.62.p261270
|View full text |Cite
|
Sign up to set email alerts
|

Experimental pharmacological research regarding the antidepressant effect of associating doxepin and selegiline in normal mice

Abstract: The severity and complexity of depression can vary widely among individuals, thus making single drug therapy ineffective in some cases. Taking this fact into account and using a mouse model, we set on investigating the possibility of obtaining a synergism of action between a classical tricyclic antidepressant that inhibits noradrenalin and serotonin reuptake (doxepin), and a modern antidepressant that inhibits type-B monoamine oxidase (selegiline). We measured the antidepressant effect using the forced swimmin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
2
2

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 13 publications
(14 reference statements)
0
2
0
Order By: Relevance
“…We then separated the mice into two groups: one treated with 5 mg/kg doxepin (Sigma-Aldrich, St Louis, MO, USA) and another treated with saline (vehicle control) via daily gavage for the final 56 days of the HFD-feeding duration (39.38 ± 0.96 g for treated mice vs. 39.48 ± 1.23 g for control mice, p > 0.05). Here we based the doxepin dosage on mouse studies on how doxepin affects glucose homeostasis, behavior, depression, stress, and memory deficits [ 29 , 81 , 82 ]. In our preliminary investigation, obese mice were orally administered 2 mg/kg doxepin; however, their body weight and body weight gain at this dosage did not differ significantly from those of the obese control mice ( Figure S10 ).…”
Section: Methodsmentioning
confidence: 99%
“…We then separated the mice into two groups: one treated with 5 mg/kg doxepin (Sigma-Aldrich, St Louis, MO, USA) and another treated with saline (vehicle control) via daily gavage for the final 56 days of the HFD-feeding duration (39.38 ± 0.96 g for treated mice vs. 39.48 ± 1.23 g for control mice, p > 0.05). Here we based the doxepin dosage on mouse studies on how doxepin affects glucose homeostasis, behavior, depression, stress, and memory deficits [ 29 , 81 , 82 ]. In our preliminary investigation, obese mice were orally administered 2 mg/kg doxepin; however, their body weight and body weight gain at this dosage did not differ significantly from those of the obese control mice ( Figure S10 ).…”
Section: Methodsmentioning
confidence: 99%
“…The locomotor activity was assessed using a system composed of a cage with transparent plexiglass walls (40 × 40 × 25 cm), equipped with two sets of photo beams (Ugo Basile, Gemonio, VA, Italy). Mice were placed individually in the apparatus and the total photo-beam interruptions were measured for 5 min, corresponding to total horizontal and vertical movements performed by each animal [65,66].…”
Section: Locomotor Activitymentioning
confidence: 99%